ABSTRACT
Extranodal lymphomas account for a third of all cases of non-Hodgkin lymphoma with the gastrointestinal tract being the most common extranodal site. The most common location is the stomach followed by the small intestine, colon and rectum. Colorectal lymphomas are rare and comprise 10–20% of all gastrointestinal lymphomas and only 1% of all colorectal malignancies. Presenting symptoms include abdominal pain, weight loss, and anorexia. Diagnosis depends on the clinical setting with elective cases being diagnosed with colonoscopy and emergent cases being diagnosed in the operating room. Colonic lymphomas are frequently located proximal to the hepatic flexure. Management depends on the aggressiveness of the lymphoma subtype. Indolent tumors, which are resistant to standard chemotherapeutic regimens, are treated with surgical resection. Aggressive lymphoma subtypes are managed with chemotherapy and surgery with late-stage disease patients being referred to clinical trials.
KEYWORDS
Lymphoma - non-Hodgkin lymphoma - gastrointestinal - intestinal tumors
REFERENCES
-
1 American Cancer Society .Cancer Facts and Figures 2010. Atlanta: American Cancer Society; 2010
-
2
Krol A D, le Cessie S, Snijder S, Kluin-Nelemans J C, Kluin P M, Noordijk E M.
Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry.
Ann Oncol.
2003;
(1)
131-139
-
3
Zucca E, Roggero E, Bertoni F, Cavalli F.
Primary extranodal non-Hodgkin's lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas.
Ann Oncol.
1997;
8
(8)
727-737
-
4
Sanchez-Bueno F, Garcia-Marcilla J A, Alonso J D et al..
Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma: a multivariate analysis of 76 cases.
Eur J Surg.
1998;
164
(5)
385-392
-
5
Andrews C N, John Gill M, Urbanski S J, Stewart D, Perini R, Beck P.
Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study.
Am J Gastroenterol.
2008;
103
(7)
1762-1769
-
6
Gurney K A, Cartwright R A, Gilman E A.
Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry.
Br J Cancer.
1999;
79
(11–12)
1929-1934
-
7
Romaguera J, Hagemeister F B.
Lymphoma of the colon.
Curr Opin Gastroenterol.
2005;
21
(1)
80-84
-
8
Dawson I M, Cornes J S, Morson B C.
Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis.
Br J Surg.
1961;
49
80-89
-
9
Musallam K M, Hatoum H A, Barada K et al..
Primary colorectal lymphoma.
Med Oncol.
2010;
27
(2)
249-254
-
10
Wong M T, Eu K W.
Primary colorectal lymphomas.
Colorectal Dis.
2006;
8
(7)
586-591
-
11
Gonzalez Q H, Heslin M J, Dávila-Cervantes A et al..
Primary colonic lymphoma.
Am Surg.
2008;
74
(3)
214-216
-
12
Fan C W, Changchien C R, Wang J Y et al..
Primary colorectal lymphoma.
Dis Colon Rectum.
2000;
43
(9)
1277-1282
-
13
Doolabh N, Anthony T, Simmang C et al..
Primary colonic lymphoma.
J Surg Oncol.
2000;
74
(4)
257-262
-
14
Avilés A, Neri N, Huerta-Guzmán J.
Large bowel lymphoma: an analysis of prognostic factors and therapy in 53 patients.
J Surg Oncol.
2002;
80
(2)
111-115
-
15
Zighelboim J, Larson M V.
Primary colonic lymphoma.
J Clin Gastroenterol.
1994;
18
(4)
291-297
-
16
Aragón Sánchez F J, García Molina F J, Rodríguez Fernández A et al..
Primary colorectal lymphoma.
Rev Esp Enferm Dig.
1997;
89
(12)
903-918
-
17
Kim Y H, Lee J H, Yang S K et al..
Primary colon lymphoma in Korea: a KASID (Korean association for the study of intestinal diseases) Study.
Dig Dis Sci.
2005;
50
(12)
2243-2247
-
18
Waisberg J, Bromberg S H, Franco M I et al..
Primary non-Hodgkin lymphoma of the right colon: a retrospective clinical-pathological study.
Int Surg.
2001;
86
(1)
20-25
-
19
Zinzani P L, Magagnoli M, Pagliani G et al..
Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.
Haematologica.
1997;
82
(3)
305-308
-
20
Otter R, Bieger R, Kluin P M, Hermans J, Willemze R.
Primary gastrointestinal non-Hodgkin's lymphoma in a population-based registry.
Br J Cancer.
1989;
60
(5)
745-750
-
21
Ducreux M, Boutron M C, Piard F, Carli P M, Faivre J.
A 15-year series of gastrointestinal non-Hodgkin's lymphomas: a population-based study.
Br J Cancer.
1998;
77
(3)
511-514
-
22
d'Amore F, Brincker H, Grønbaek K Danish Lymphoma Study Group et al.
Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis.
J Clin Oncol.
1994;
12
(8)
1673-1684
-
23
Hansen P B, Vogt K C, Skov R L, Pedersen-Bjergaard U, Jacobsen M, Ralfkiaer E.
Primary gastrointestinal non-Hodgkin's lymphoma in adults: a population-based clinical and histopathologic study.
J Intern Med.
1998;
244
(1)
71-78
-
24
Halme L, Mecklin J P, Juhola M, Krees R, Palmu A.
Primary gastrointestinal non-Hodgkin's lymphoma. A population based study in central Finland in 1975-1993.
Acta Oncol.
1997;
36
(1)
69-74
-
25
Musshoff K.
Klinische stadieneinteilung der nicht-Hodgkin's lymphoma.
Strahlentherapie.
1977;
153
218-221
-
26
Sohn S K, Dong-Hwan K, Jin T J et al..
Comparison of clinical staging systems in primary gastrointestinal NHL.
Proc Am Soc Clin Oncol.
2000;
19
abstract 162
-
27
Boot H.
Diagnosis and staging in gastrointestinal lymphoma.
Best Pract Res Clin Gastroenterol.
2010;
24
(1)
3-12
-
28
de Jong D, Balagué Ponz O.
The molecular background of aggressive B cell lymphomas as a basis for targeted therapy.
J Pathol.
2011;
223
(2)
274-282
-
29
Koniaris L G, Drugas G, Katzman P J, Salloum R.
Management of gastrointestinal lymphoma.
J Am Coll Surg.
2003;
197
(1)
127-141
-
30 Swerdlow S H, Campo E, Harris N L et al.. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. (4th ed.). Lyon, France: IARC Press; 2008
-
31
Cavalli F, Isaacson P G, Gascoyne R D, Zucca E.
MALT lymphomas.
Hematology (Am Soc Hematol Educ Program).
2001;
241-258
-
32
Bellan C, Stefano L, Giulia F, Rogena E A, Lorenzo L.
Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.
Hematol Oncol.
2010;
28
(2)
53-56
-
33
Quayle F J, Lowney J K.
Colorectal lymphoma.
Clin Colon Rectal Surg.
2006;
19
(2)
49-53
-
34
Breslin N P, Urbanski S J, Shaffer E A.
Mucosa-associated lymphoid tissue (MALT) lymphoma manifesting as multiple lymphomatosis polyposis of the gastrointestinal tract.
Am J Gastroenterol.
1999;
94
(9)
2540-2545
-
35
Myung S J, Joo K R, Yang S K et al..
Clinicopathologic features of ileocolonic malignant lymphoma: analysis according to colonoscopic classification.
Gastrointest Endosc.
2003;
57
(3)
343-347
-
36
Lee H J, Han J K, Kim T K et al..
Primary colorectal lymphoma: spectrum of imaging findings with pathologic correlation.
Eur Radiol.
2002;
12
(9)
2242-2249
-
37
Gollub M J.
Imaging of gastrointestinal lymphoma.
Radiol Clin North Am.
2008;
46
(2)
287-312
ix
-
38
Ghai S, Pattison J, Ghai S, O'Malley M E, Khalili K, Stephens M.
Primary gastrointestinal lymphoma: spectrum of imaging findings with pathologic correlation.
Radiographics.
2007;
27
(5)
1371-1388
-
39
Engin G, Korman U.
Gastrointestinal lymphoma: a spectrum of fluoroscopic and CT findings.
Diagn Interv Radiol.
2010;
August 20 [Epub ahead of print]
-
40
Zinzani P L, Chierichetti F, Zompatori M et al..
Advantages of positron emission tomography (PET) with respect to computed tomography in the follow-up of lymphoma patients with abdominal presentation.
Leuk Lymphoma.
2002;
43
(6)
1239-1243
-
41
Zinzani P L, Fanti S, Battista G et al..
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.
Br J Cancer.
2004;
91
(5)
850-854
-
42
Michallet A S, Trotman J, Tychyj-Pinel C.
Role of early PET in the management of diffuse large B-cell lymphoma.
Curr Opin Oncol.
2010;
22
(5)
414-418
-
43
Terasawa T, Lau J, Bardet S et al..
Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review.
J Clin Oncol.
2009;
27
(11)
1906-1914
-
44
Ernst M, Stein H, Ludwig D, Boese-Landgraf J, Ritz J, Häring R.
Surgical therapy of gastrointestinal non-Hodgkin's lymphomas.
Eur J Surg Oncol.
1996;
22
(2)
177-181
-
45
Cai S, Cannizzo Jr F, Bullard Dunn K M, Gibbs J F, Czuczman M, Rajput A.
The role of surgical intervention in non-Hodgkin's lymphoma of the colon and rectum.
Am J Surg.
2007;
193
(3)
409-412, discussion 412
-
46 Guidelines of the National Comprehensive Cancer Network .Non-Hodgkin's lymphomas. Version 1. Fort Washington, PA: National Comprehensive Cancer Network; 2011
-
47
Shia J, Teruya-Feldstein J, Pan D et al..
Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 cases.
Am J Surg Pathol.
2002;
26
(2)
216-224
-
48
Feng S, Buell J F, Chari R S, DiMaio J M, Hanto D W.
Tumors and transplantation: the 2003 third annual ASTS State-of-the-Art Winter Symposium.
Am J Transplant.
2003;
3
(12)
1481-1487
-
49
Boubenider S, Hiesse C, Goupy C, Kriaa F, Marchand S, Charpentier B.
Incidence and consequences of post-transplantation lymphoproliferative disorders.
J Nephrol.
1997;
10
(3)
136-145
-
50
Allen U, Hébert D, Moore D, Dror Y, Wasfy S. Canadian PTLD Survey Group--1998 .
Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplant recipients, 1988-97: a Canadian multi-centre experience.
Pediatr Transplant.
2001;
5
(3)
198-203
-
51
Leblond V, Sutton L, Dorent R et al..
Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.
J Clin Oncol.
1995;
13
(4)
961-968
-
52
Parker A, Bowles K, Bradley J A Haemato-oncology Task Force of the British Committee for Standards in Haematology and British Transplantation Society et al.
Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients-BCSH and BTS Guidelines.
Br J Haematol.
2010;
149
(5)
675-692
-
53
Knight J S, Tsodikov A, Cibrik D M, Ross C W, Kaminski M S, Blayney D W.
Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
J Clin Oncol.
2009;
27
(20)
3354-3362
-
54
Holubar S D, Dozois E J, Loftus E V et al..
Primary intestinal lymphoma in patients with inflammatory bowel disease: a descriptive series from the prebiologic therapy era.
Inflamm Bowel Dis.
2010;
November 4 [Epub ahead of print]
-
55
Smedby K E, Hjalgrim H, Askling J et al..
Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
J Natl Cancer Inst.
2006;
98
(1)
51-60
-
56
Centers for Disease Control and Prevention .
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.
MMWR Recomm Rep.
1992;
41
(RR-17)
1-19
-
57
Engels E A, Biggar R J, Hall H I et al..
Cancer risk in people infected with human immunodeficiency virus in the United States.
Int J Cancer.
2008;
123
(1)
187-194
-
58
Simard E P, Pfeiffer R M, Engels E A.
Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States.
Cancer.
2011;
117
(5)
1089-1096
Melissa TimesM.D.
Division of Colon and Rectal Surgery, Henry Ford Hospital
2799 W. Grand Blvd., Detroit, MI 48202
Email: mtimes1@hfhs.org
